Trakul Nicholas, Rosner Marsha R
Ben May Institute for Cancer Research, University of Chicago, 5841 S. Maryland Avenue., Chicago, IL 60637, USA.
Cell Res. 2005 Jan;15(1):19-23. doi: 10.1038/sj.cr.7290258.
Proteins like Raf kinase inhibitory protein (RKIP) that serve as modulators of signaling pathways, either by promoting or inhibiting the formation of productive signaling complexes through protein-protein interactions, have been demonstrated to play an increasingly important role in a number of cell types and organisms. These proteins have been implicated in development as well as the progression of cancer. RKIP is a particularly interesting regulator, as it is a highly conserved, ubiquitously expressed protein that has been shown to play a role in growth and differentiation in a number of organisms and can regulate multiple signaling pathways. RKIP is also the first MAP kinase signaling modulator to be identified as playing a role in cancer metastasis, and identification of the mechanism by which it regulates Raf-1 activation provides new targets for therapeutic intervention.
像Raf激酶抑制蛋白(RKIP)这样的蛋白质,作为信号通路的调节剂,通过蛋白质-蛋白质相互作用促进或抑制有活性的信号复合物的形成,已被证明在许多细胞类型和生物体中发挥着越来越重要的作用。这些蛋白质与发育以及癌症进展有关。RKIP是一种特别有趣的调节剂,因为它是一种高度保守、广泛表达的蛋白质,已被证明在许多生物体的生长和分化中发挥作用,并且可以调节多种信号通路。RKIP也是第一个被确定在癌症转移中起作用的MAP激酶信号调节剂,对其调节Raf-1激活机制的鉴定为治疗干预提供了新的靶点。